Allarity Therapeutics, Inc. (ALLR) Stock Price, Latest News, Company Profile & Institutional Holding

#ThinkSabio Latest News

Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025.

Light
Dark